img

Global and United States mRNA Vaccines and mRNA Drugs Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States mRNA Vaccines and mRNA Drugs Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States mRNA Vaccines and mRNA Drugs Market
This report focuses on global and United States mRNA Vaccines and mRNA Drugs market, also covers the segmentation data of other regions in regional level and county level.
The global mRNA Vaccines and mRNA Drugs revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during the forecast period (2024-2034).
In United States the mRNA Vaccines and mRNA Drugs revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2024-2034).
The global key players of mRNA Vaccines and mRNA Drugs include Thermo Fisher, Merck, Qiagen N.V., CureVac, In-Cell-Art, eTheRNA, Takara Bio Inc., Sangamo Therapeutics and Roche CustomBiotech, etc. The global five biggest players hold a share of % in 2022.
Global mRNA Vaccines and mRNA Drugs Scope and Market Size
mRNA Vaccines and mRNA Drugs market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global mRNA Vaccines and mRNA Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For United States market, this report focuses on the mRNA Vaccines and mRNA Drugs market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in United States.



By Company


Thermo Fisher
Merck
Qiagen N.V.
CureVac
In-Cell-Art
eTheRNA
Takara Bio Inc.
Sangamo Therapeutics
Roche CustomBiotech
BioNTech
Tiba Biotechnology
TriLink Bio Technologies
Argos Therapeutics
Moderna Therapeutics
NEB
Ethris
Aldevron
Promega
Translate Bio
Segment by Type
Vaccine
API

Segment by Application


Infectious Disease
Cancer
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces mRNA Vaccines and mRNA Drugs definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of mRNA Vaccines and mRNA Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of mRNA Vaccines and mRNA Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Vaccines and mRNA Drugs sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 mRNA Vaccines and mRNA Drugs Product Introduction
1.2 Global mRNA Vaccines and mRNA Drugs Outlook 2018 VS 2022 VS 2029
1.2.1 Global mRNA Vaccines and mRNA Drugs Sales in US$ Million for the Year 2018-2029
1.2.2 Global mRNA Vaccines and mRNA Drugs Sales in Volume for the Year 2018-2029
1.3 United States mRNA Vaccines and mRNA Drugs Outlook 2018 VS 2022 VS 2029
1.3.1 United States mRNA Vaccines and mRNA Drugs Sales in US$ Million for the Year 2018-2029
1.3.2 United States mRNA Vaccines and mRNA Drugs Sales in Volume for the Year 2018-2029
1.4 mRNA Vaccines and mRNA Drugs Market Size, United States VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of United States mRNA Vaccines and mRNA Drugs in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of mRNA Vaccines and mRNA Drugs Market Size, United States VS Global, 2018 VS 2022 VS 2029
1.5 mRNA Vaccines and mRNA Drugs Market Dynamics
1.5.1 mRNA Vaccines and mRNA Drugs Industry Trends
1.5.2 mRNA Vaccines and mRNA Drugs Market Drivers
1.5.3 mRNA Vaccines and mRNA Drugs Market Challenges
1.5.4 mRNA Vaccines and mRNA Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 mRNA Vaccines and mRNA Drugs by Type
2.1 mRNA Vaccines and mRNA Drugs Market Segment by Type
2.1.1 Vaccine
2.1.2 API
2.2 Global mRNA Vaccines and mRNA Drugs Market Size by Type
2.2.1 Global mRNA Vaccines and mRNA Drugs Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global mRNA Vaccines and mRNA Drugs Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global mRNA Vaccines and mRNA Drugs Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 United States mRNA Vaccines and mRNA Drugs Market Size by Type
2.3.1 United States mRNA Vaccines and mRNA Drugs Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 United States mRNA Vaccines and mRNA Drugs Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 United States mRNA Vaccines and mRNA Drugs Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 mRNA Vaccines and mRNA Drugs by Application
3.1 mRNA Vaccines and mRNA Drugs Market Segment by Application
3.1.1 Infectious Disease
3.1.2 Cancer
3.2 Global mRNA Vaccines and mRNA Drugs Market Size by Application
3.2.1 Global mRNA Vaccines and mRNA Drugs Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global mRNA Vaccines and mRNA Drugs Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global mRNA Vaccines and mRNA Drugs Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 United States mRNA Vaccines and mRNA Drugs Market Size by Application
3.3.1 United States mRNA Vaccines and mRNA Drugs Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 United States mRNA Vaccines and mRNA Drugs Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 United States mRNA Vaccines and mRNA Drugs Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global mRNA Vaccines and mRNA Drugs Competitor Landscape by Company
4.1 Global mRNA Vaccines and mRNA Drugs Market Size by Company
4.1.1 Global Key Manufacturers of mRNA Vaccines and mRNA Drugs, Ranked by Revenue (2022)
4.1.2 Global mRNA Vaccines and mRNA Drugs Revenue by Manufacturer (2018-2024)
4.1.3 Global mRNA Vaccines and mRNA Drugs Sales by Manufacturer (2018-2024)
4.1.4 Global mRNA Vaccines and mRNA Drugs Price by Manufacturer (2018-2024)
4.2 Global mRNA Vaccines and mRNA Drugs Concentration Ratio (CR)
4.2.1 mRNA Vaccines and mRNA Drugs Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of mRNA Vaccines and mRNA Drugs in 2022
4.2.3 Global mRNA Vaccines and mRNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of mRNA Vaccines and mRNA Drugs, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of mRNA Vaccines and mRNA Drugs, Product Offered and Application
4.5 Global Key Manufacturers of mRNA Vaccines and mRNA Drugs, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States mRNA Vaccines and mRNA Drugs Market Size by Company
4.7.1 Key Players of mRNA Vaccines and mRNA Drugs in United States, Ranked by Revenue (2022)
4.7.2 United States mRNA Vaccines and mRNA Drugs Revenue by Players (2018-2024)
4.7.3 United States mRNA Vaccines and mRNA Drugs Sales by Players (2018-2024)
5 Global mRNA Vaccines and mRNA Drugs Market Size by Region
5.1 Global mRNA Vaccines and mRNA Drugs Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global mRNA Vaccines and mRNA Drugs Market Size in Volume by Region (2018-2029)
5.2.1 Global mRNA Vaccines and mRNA Drugs Sales in Volume by Region: 2018-2024
5.2.2 Global mRNA Vaccines and mRNA Drugs Sales in Volume Forecast by Region (2024-2029)
5.3 Global mRNA Vaccines and mRNA Drugs Market Size in Value by Region (2018-2029)
5.3.1 Global mRNA Vaccines and mRNA Drugs Sales in Value by Region: 2018-2024
5.3.2 Global mRNA Vaccines and mRNA Drugs Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas mRNA Vaccines and mRNA Drugs Market Size YoY Growth 2018-2029
6.2 Americas mRNA Vaccines and mRNA Drugs Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas mRNA Vaccines and mRNA Drugs Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas mRNA Vaccines and mRNA Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas mRNA Vaccines and mRNA Drugs Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas mRNA Vaccines and mRNA Drugs Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA mRNA Vaccines and mRNA Drugs Market Size YoY Growth 2018-2029
7.2 EMEA mRNA Vaccines and mRNA Drugs Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA mRNA Vaccines and mRNA Drugs Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA mRNA Vaccines and mRNA Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA mRNA Vaccines and mRNA Drugs Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA mRNA Vaccines and mRNA Drugs Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China mRNA Vaccines and mRNA Drugs Market Size YoY Growth 2018-2029
8.2 China mRNA Vaccines and mRNA Drugs Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China mRNA Vaccines and mRNA Drugs Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC mRNA Vaccines and mRNA Drugs Market Size YoY Growth 2018-2029
9.2 APAC mRNA Vaccines and mRNA Drugs Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC mRNA Vaccines and mRNA Drugs Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC mRNA Vaccines and mRNA Drugs Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC mRNA Vaccines and mRNA Drugs Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC mRNA Vaccines and mRNA Drugs Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Thermo Fisher
10.1.1 Thermo Fisher Company Information
10.1.2 Thermo Fisher Description and Business Overview
10.1.3 Thermo Fisher mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Thermo Fisher mRNA Vaccines and mRNA Drugs Products Offered
10.1.5 Thermo Fisher Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Description and Business Overview
10.2.3 Merck mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck mRNA Vaccines and mRNA Drugs Products Offered
10.2.5 Merck Recent Development
10.3 Qiagen N.V.
10.3.1 Qiagen N.V. Company Information
10.3.2 Qiagen N.V. Description and Business Overview
10.3.3 Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Qiagen N.V. mRNA Vaccines and mRNA Drugs Products Offered
10.3.5 Qiagen N.V. Recent Development
10.4 CureVac
10.4.1 CureVac Company Information
10.4.2 CureVac Description and Business Overview
10.4.3 CureVac mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 CureVac mRNA Vaccines and mRNA Drugs Products Offered
10.4.5 CureVac Recent Development
10.5 In-Cell-Art
10.5.1 In-Cell-Art Company Information
10.5.2 In-Cell-Art Description and Business Overview
10.5.3 In-Cell-Art mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 In-Cell-Art mRNA Vaccines and mRNA Drugs Products Offered
10.5.5 In-Cell-Art Recent Development
10.6 eTheRNA
10.6.1 eTheRNA Company Information
10.6.2 eTheRNA Description and Business Overview
10.6.3 eTheRNA mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 eTheRNA mRNA Vaccines and mRNA Drugs Products Offered
10.6.5 eTheRNA Recent Development
10.7 Takara Bio Inc.
10.7.1 Takara Bio Inc. Company Information
10.7.2 Takara Bio Inc. Description and Business Overview
10.7.3 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Products Offered
10.7.5 Takara Bio Inc. Recent Development
10.8 Sangamo Therapeutics
10.8.1 Sangamo Therapeutics Company Information
10.8.2 Sangamo Therapeutics Description and Business Overview
10.8.3 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Products Offered
10.8.5 Sangamo Therapeutics Recent Development
10.9 Roche CustomBiotech
10.9.1 Roche CustomBiotech Company Information
10.9.2 Roche CustomBiotech Description and Business Overview
10.9.3 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Products Offered
10.9.5 Roche CustomBiotech Recent Development
10.10 BioNTech
10.10.1 BioNTech Company Information
10.10.2 BioNTech Description and Business Overview
10.10.3 BioNTech mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 BioNTech mRNA Vaccines and mRNA Drugs Products Offered
10.10.5 BioNTech Recent Development
10.11 Tiba Biotechnology
10.11.1 Tiba Biotechnology Company Information
10.11.2 Tiba Biotechnology Description and Business Overview
10.11.3 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Products Offered
10.11.5 Tiba Biotechnology Recent Development
10.12 TriLink Bio Technologies
10.12.1 TriLink Bio Technologies Company Information
10.12.2 TriLink Bio Technologies Description and Business Overview
10.12.3 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Products Offered
10.12.5 TriLink Bio Technologies Recent Development
10.13 Argos Therapeutics
10.13.1 Argos Therapeutics Company Information
10.13.2 Argos Therapeutics Description and Business Overview
10.13.3 Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Argos Therapeutics mRNA Vaccines and mRNA Drugs Products Offered
10.13.5 Argos Therapeutics Recent Development
10.14 Moderna Therapeutics
10.14.1 Moderna Therapeutics Company Information
10.14.2 Moderna Therapeutics Description and Business Overview
10.14.3 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Products Offered
10.14.5 Moderna Therapeutics Recent Development
10.15 NEB
10.15.1 NEB Company Information
10.15.2 NEB Description and Business Overview
10.15.3 NEB mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.15.4 NEB mRNA Vaccines and mRNA Drugs Products Offered
10.15.5 NEB Recent Development
10.16 Ethris
10.16.1 Ethris Company Information
10.16.2 Ethris Description and Business Overview
10.16.3 Ethris mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Ethris mRNA Vaccines and mRNA Drugs Products Offered
10.16.5 Ethris Recent Development
10.17 Aldevron
10.17.1 Aldevron Company Information
10.17.2 Aldevron Description and Business Overview
10.17.3 Aldevron mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Aldevron mRNA Vaccines and mRNA Drugs Products Offered
10.17.5 Aldevron Recent Development
10.18 Promega
10.18.1 Promega Company Information
10.18.2 Promega Description and Business Overview
10.18.3 Promega mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Promega mRNA Vaccines and mRNA Drugs Products Offered
10.18.5 Promega Recent Development
10.19 Translate Bio
10.19.1 Translate Bio Company Information
10.19.2 Translate Bio Description and Business Overview
10.19.3 Translate Bio mRNA Vaccines and mRNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Translate Bio mRNA Vaccines and mRNA Drugs Products Offered
10.19.5 Translate Bio Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 mRNA Vaccines and mRNA Drugs Industry Chain Analysis
11.2 mRNA Vaccines and mRNA Drugs Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 mRNA Vaccines and mRNA Drugs Production Mode & Process
11.4 mRNA Vaccines and mRNA Drugs Sales and Marketing
11.4.1 mRNA Vaccines and mRNA Drugs Sales Channels
11.4.2 mRNA Vaccines and mRNA Drugs Distributors
11.5 mRNA Vaccines and mRNA Drugs Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. mRNA Vaccines and mRNA Drugs CAGR in Value, United States VS Global, 2018 VS 2022 VS 2029
Table 2. mRNA Vaccines and mRNA Drugs Market Trends
Table 3. mRNA Vaccines and mRNA Drugs Market Drivers
Table 4. mRNA Vaccines and mRNA Drugs Market Challenges
Table 5. mRNA Vaccines and mRNA Drugs Market Restraints
Table 6. Global mRNA Vaccines and mRNA Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. United States mRNA Vaccines and mRNA Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global mRNA Vaccines and mRNA Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. United States mRNA Vaccines and mRNA Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Manufacturers of mRNA Vaccines and mRNA Drugs, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global mRNA Vaccines and mRNA Drugs Revenue by Manufacturer, (US$ Million), 2018-2024
Table 12. Global mRNA Vaccines and mRNA Drugs Revenue Share by Manufacturer, 2018-2024
Table 13. Global mRNA Vaccines and mRNA Drugs Sales by Manufacturer, (K Units), 2018-2024
Table 14. Global mRNA Vaccines and mRNA Drugs Sales Share by Manufacturer, 2018-2024
Table 15. Global mRNA Vaccines and mRNA Drugs Price by Manufacturer (2018-2024) & (US$/Unit)
Table 16. Global mRNA Vaccines and mRNA Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global mRNA Vaccines and mRNA Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines and mRNA Drugs as of 2022)
Table 18. Global Key Manufacturers of mRNA Vaccines and mRNA Drugs, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of mRNA Vaccines and mRNA Drugs, Product Offered and Application
Table 20. Global Key Manufacturers of mRNA Vaccines and mRNA Drugs, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of mRNA Vaccines and mRNA Drugs in United States, Ranked by Revenue (2022) & (US$ million)
Table 23. United States mRNA Vaccines and mRNA Drugs Revenue by Players, (US$ Million), (2018-2024)
Table 24. United States mRNA Vaccines and mRNA Drugs Revenue Share by Players, (2018-2024)
Table 25. United States mRNA Vaccines and mRNA Drugs Sales by Players, (K Units), (2018-2024)
Table 26. United States mRNA Vaccines and mRNA Drugs Sales Share by Players, (2018-2024)
Table 27. Global mRNA Vaccines and mRNA Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 28. Global mRNA Vaccines and mRNA Drugs Sales in Volume by Region (2018-2024) & (K Units)
Table 29. Global mRNA Vaccines and mRNA Drugs Sales in Volume Forecast by Region (2024-2029) & (K Units)
Table 30. Global mRNA Vaccines and mRNA Drugs Sales in Value by Region (2018-2024) & (US$ Million)
Table 31. Global mRNA Vaccines and mRNA Drugs Sales in Value Forecast by Region (2024-2029) & (US$ Million)
Table 32. Americas mRNA Vaccines and mRNA Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. Americas mRNA Vaccines and mRNA Drugs Sales in Value by Country (2018-2024) & (US$ Million)
Table 34. Americas mRNA Vaccines and mRNA Drugs Sales in Value by Country (2024-2029) & (US$ Million)
Table 35. Americas mRNA Vaccines and mRNA Drugs Sales in Volume by Country (2018-2024) & (K Units)
Table 36. Americas mRNA Vaccines and mRNA Drugs Sales in Volume by Country (2024-2029) & (K Units)
Table 37. EMEA mRNA Vaccines and mRNA Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. EMEA mRNA Vaccines and mRNA Drugs Sales in Value by Country (2018-2024) & (US$ Million)
Table 39. EMEA mRNA Vaccines and mRNA Drugs Sales in Value by Country (2024-2029) & (US$ Million)
Table 40. EMEA mRNA Vaccines and mRNA Drugs Sales in Volume by Country (2018-2024) & (K Units)
Table 41. EMEA mRNA Vaccines and mRNA Drugs Sales in Volume by Country (2024-2029) & (K Units)
Table 42. APAC mRNA Vaccines and mRNA Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. APAC mRNA Vaccines and mRNA Drugs Sales in Value by Country (2018-2024) & (US$ Million)
Table 44. APAC mRNA Vaccines and mRNA Drugs Sales in Value by Country (2024-2029) & (US$ Million)
Table 45. APAC mRNA Vaccines and mRNA Drugs Sales in Volume by Country (2018-2024) & (K Units)
Table 46. APAC mRNA Vaccines and mRNA Drugs Sales in Volume by Country (2024-2029) & (K Units)
Table 47. Thermo Fisher Company Information
Table 48. Thermo Fisher Description and Business Overview
Table 49. Thermo Fisher mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 50. Thermo Fisher mRNA Vaccines and mRNA Drugs Product
Table 51. Thermo Fisher Recent Development
Table 52. Merck Company Information
Table 53. Merck Description and Business Overview
Table 54. Merck mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 55. Merck mRNA Vaccines and mRNA Drugs Product
Table 56. Merck Recent Development
Table 57. Qiagen N.V. Company Information
Table 58. Qiagen N.V. Description and Business Overview
Table 59. Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 60. Qiagen N.V. mRNA Vaccines and mRNA Drugs Product
Table 61. Qiagen N.V. Recent Development
Table 62. CureVac Company Information
Table 63. CureVac Description and Business Overview
Table 64. CureVac mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 65. CureVac mRNA Vaccines and mRNA Drugs Product
Table 66. CureVac Recent Development
Table 67. In-Cell-Art Company Information
Table 68. In-Cell-Art Description and Business Overview
Table 69. In-Cell-Art mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 70. In-Cell-Art mRNA Vaccines and mRNA Drugs Product
Table 71. In-Cell-Art Recent Development
Table 72. eTheRNA Company Information
Table 73. eTheRNA Description and Business Overview
Table 74. eTheRNA mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 75. eTheRNA mRNA Vaccines and mRNA Drugs Product
Table 76. eTheRNA Recent Development
Table 77. Takara Bio Inc. Company Information
Table 78. Takara Bio Inc. Description and Business Overview
Table 79. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 80. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product
Table 81. Takara Bio Inc. Recent Development
Table 82. Sangamo Therapeutics Company Information
Table 83. Sangamo Therapeutics Description and Business Overview
Table 84. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 85. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product
Table 86. Sangamo Therapeutics Recent Development
Table 87. Roche CustomBiotech Company Information
Table 88. Roche CustomBiotech Description and Business Overview
Table 89. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 90. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product
Table 91. Roche CustomBiotech Recent Development
Table 92. BioNTech Company Information
Table 93. BioNTech Description and Business Overview
Table 94. BioNTech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 95. BioNTech mRNA Vaccines and mRNA Drugs Product
Table 96. BioNTech Recent Development
Table 97. Tiba Biotechnology Company Information
Table 98. Tiba Biotechnology Description and Business Overview
Table 99. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 100. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product
Table 101. Tiba Biotechnology Recent Development
Table 102. TriLink Bio Technologies Company Information
Table 103. TriLink Bio Technologies Description and Business Overview
Table 104. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 105. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product
Table 106. TriLink Bio Technologies Recent Development
Table 107. Argos Therapeutics Company Information
Table 108. Argos Therapeutics Description and Business Overview
Table 109. Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Argos Therapeutics mRNA Vaccines and mRNA Drugs Product
Table 111. Argos Therapeutics Recent Development
Table 112. Moderna Therapeutics Company Information
Table 113. Moderna Therapeutics Description and Business Overview
Table 114. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product
Table 116. Moderna Therapeutics Recent Development
Table 117. NEB Company Information
Table 118. NEB Description and Business Overview
Table 119. NEB mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. NEB mRNA Vaccines and mRNA Drugs Product
Table 121. NEB Recent Development
Table 122. Ethris Company Information
Table 123. Ethris Description and Business Overview
Table 124. Ethris mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Ethris mRNA Vaccines and mRNA Drugs Product
Table 126. Ethris Recent Development
Table 127. Aldevron Company Information
Table 128. Aldevron Description and Business Overview
Table 129. Aldevron mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Aldevron mRNA Vaccines and mRNA Drugs Product
Table 131. Aldevron Recent Development
Table 132. Promega Company Information
Table 133. Promega Description and Business Overview
Table 134. Promega mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Promega mRNA Vaccines and mRNA Drugs Product
Table 136. Promega Recent Development
Table 137. Translate Bio Company Information
Table 138. Translate Bio Description and Business Overview
Table 139. Translate Bio mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Translate Bio mRNA Vaccines and mRNA Drugs Product
Table 141. Translate Bio Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. mRNA Vaccines and mRNA Drugs Customers List
Table 145. mRNA Vaccines and mRNA Drugs Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Vaccines and mRNA Drugs Product Picture
Figure 2. Global mRNA Vaccines and mRNA Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global mRNA Vaccines and mRNA Drugs Market Size 2018-2029 (US$ Million)
Figure 4. Global mRNA Vaccines and mRNA Drugs Sales 2018-2029 (K Units)
Figure 5. United States mRNA Vaccines and mRNA Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 6. United States mRNA Vaccines and mRNA Drugs Market Size 2018-2029 (US$ Million)
Figure 7. United States mRNA Vaccines and mRNA Drugs Sales 2018-2029 (K Units)
Figure 8. United States mRNA Vaccines and mRNA Drugs Market Share in Global, in Value (US$ Million) 2018-2029
Figure 9. United States mRNA Vaccines and mRNA Drugs Market Share in Global, in Volume (K Units) 2018-2029
Figure 10. mRNA Vaccines and mRNA Drugs Report Years Considered
Figure 11. Product Picture of Vaccine
Figure 12. Product Picture of API
Figure 13. Global mRNA Vaccines and mRNA Drugs Market Share by Type in 2022 & 2029
Figure 14. Global mRNA Vaccines and mRNA Drugs Sales in Value by Type (2018-2029) & (US$ Million)
Figure 15. Global mRNA Vaccines and mRNA Drugs Sales Market Share in Value by Type (2018-2029)
Figure 16. Global mRNA Vaccines and mRNA Drugs Sales by Type (2018-2029) & (K Units)
Figure 17. Global mRNA Vaccines and mRNA Drugs Sales Market Share in Volume by Type (2018-2029)
Figure 18. Global mRNA Vaccines and mRNA Drugs Price by Type (2018-2029) & (US$/Unit)
Figure 19. United States mRNA Vaccines and mRNA Drugs Market Share by Type in 2022 & 2029
Figure 20. United States mRNA Vaccines and mRNA Drugs Sales in Value by Type (2018-2029) & (US$ Million)
Figure 21. United States mRNA Vaccines and mRNA Drugs Sales Market Share in Value by Type (2018-2029)
Figure 22. United States mRNA Vaccines and mRNA Drugs Sales by Type (2018-2029) & (K Units)
Figure 23. United States mRNA Vaccines and mRNA Drugs Sales Market Share in Volume by Type (2018-2029)
Figure 24. United States mRNA Vaccines and mRNA Drugs Price by Type (2018-2029) & (US$/Unit)
Figure 25. Product Picture of Infectious Disease
Figure 26. Product Picture of Cancer
Figure 27. Global mRNA Vaccines and mRNA Drugs Market Share by Application in 2022 & 2029
Figure 28. Global mRNA Vaccines and mRNA Drugs Sales in Value by Application (2018-2029) & (US$ Million)
Figure 29. Global mRNA Vaccines and mRNA Drugs Sales Market Share in Value by Application (2018-2029)
Figure 30. Global mRNA Vaccines and mRNA Drugs Sales by Application (2018-2029) & (K Units)
Figure 31. Global mRNA Vaccines and mRNA Drugs Sales Market Share in Volume by Application (2018-2029)
Figure 32. Global mRNA Vaccines and mRNA Drugs Price by Application (2018-2029) & (US$/Unit)
Figure 33. United States mRNA Vaccines and mRNA Drugs Market Share by Application in 2022 & 2029
Figure 34. United States mRNA Vaccines and mRNA Drugs Sales in Value by Application (2018-2029) & (US$ Million)
Figure 35. United States mRNA Vaccines and mRNA Drugs Sales Market Share in Value by Application (2018-2029)
Figure 36. United States mRNA Vaccines and mRNA Drugs Sales by Application (2018-2029) & (K Units)
Figure 37. United States mRNA Vaccines and mRNA Drugs Sales Market Share in Volume by Application (2018-2029)
Figure 38. United States mRNA Vaccines and mRNA Drugs Price by Application (2018-2029) & (US$/Unit)
Figure 39. Americas mRNA Vaccines and mRNA Drugs Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 40. Americas mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 41. Americas mRNA Vaccines and mRNA Drugs Sales by Type (2018-2029) & (K Units)
Figure 42. Americas mRNA Vaccines and mRNA Drugs Sales Market Share in Volume by Type (2018-2029)
Figure 43. Americas mRNA Vaccines and mRNA Drugs Sales by Application (2018-2029) & (K Units)
Figure 44. Americas mRNA Vaccines and mRNA Drugs Sales Market Share in Volume by Application (2018-2029)
Figure 45. United States mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 46. Canada mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 47. Mexico mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 49. EMEA mRNA Vaccines and mRNA Drugs Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 50. EMEA mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 51. EMEA mRNA Vaccines and mRNA Drugs Sales by Type (2018-2029) & (K Units)
Figure 52. EMEA mRNA Vaccines and mRNA Drugs Sales Market Share in Volume by Type (2018-2029)
Figure 53. EMEA mRNA Vaccines and mRNA Drugs Sales by Application (2018-2029) & (K Units)
Figure 54. EMEA mRNA Vaccines and mRNA Drugs Sales Market Share in Volume by Application (2018-2029)
Figure 55. Europe mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 56. Middle East mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 57. Africa mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 58. China mRNA Vaccines and mRNA Drugs Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 59. China mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 60. China mRNA Vaccines and mRNA Drugs Sales by Type (2018-2029) & (K Units)
Figure 61. China mRNA Vaccines and mRNA Drugs Sales Market Share in Volume by Type (2018-2029)
Figure 62. China mRNA Vaccines and mRNA Drugs Sales by Application (2018-2029) & (K Units)
Figure 63. China mRNA Vaccines and mRNA Drugs Sales Market Share in Volume by Application (2018-2029)
Figure 64. APAC mRNA Vaccines and mRNA Drugs Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 65. APAC mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 66. APAC mRNA Vaccines and mRNA Drugs Sales by Type (2018-2029) & (K Units)
Figure 67. APAC mRNA Vaccines and mRNA Drugs Sales Market Share in Volume by Type (2018-2029)
Figure 68. APAC mRNA Vaccines and mRNA Drugs Sales by Application (2018-2029) & (K Units)
Figure 69. APAC mRNA Vaccines and mRNA Drugs Sales Market Share in Volume by Application (2018-2029)
Figure 70. Japan mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 71. South Korea mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 72. China Taiwan mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 73. Southeast Asia mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 74. India mRNA Vaccines and mRNA Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 75. mRNA Vaccines and mRNA Drugs Value Chain
Figure 76. mRNA Vaccines and mRNA Drugs Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed